Parexel扩大与Medidata的战略伙伴关系,加强分散式临床试验交付
纽约 Dassault Systèmes旗下的Medidata今天宣布,全球领先的专注于开发和提供创新疗法以促进患者健康的临床研究组织Parexel将延长双方15年的全球战略伙伴关系。这一举措建立在双方的互信关系基础之上,并确立了共同为生命科学行业开创分散式临床试验技术(DCT)新纪元的目标。 Parexel首席患者官Clare...
View ArticleAHF Launches #CondomEmoji Campaign on International Condom Day!
LOS ANGELES International Condom Day (ICD) 2022 has arrived! AIDS Healthcare Foundation (AHF) has been dropping hints throughout our recent ICD messages, and we’re so happy to finally give you the...
View ArticleIktos and Teijin Pharma to Co-Develop New Technology for Small Molecule Drug...
PARIS & TOKYO Iktos, a company specialized in Artificial Intelligence (AI) for new drug design, and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business that...
View ArticleTakeda and the New York Academy of Sciences Announce 2022 Innovators in...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda (TSE:4502/NYSE:TAK) and the New York Academy of Sciences today announced the winners of the fourth Innovators in Science Award for their excellence in, and...
View Article南アフリカの教育病院が環境衛生の新規介入によりCREスーパー耐性菌の低減を達成
ヨハネスブルク (ビジネスワイヤ) — ウィッツ大学ドナルド・ゴードン・メディカル・センターは、紫外線(UV)室内汚染除去技術と手動清掃プロトコルの組み合わせにより、病院環境におけるカルバペネム耐性腸内細菌科細菌(CRE)の感染が23%低減したことを初めて示す新しい研究結果を発表しました。この研究結果は、The Journal of Hospital...
View ArticleHEAL Partners announces Strategic Relationship With Elliott Investment...
SYDNEY HEAL Partners, an Australia and Cayman based global Growth and Follow-On Fund specialising in Health, Education and Lifestyle sector investments (“HEAL”), today announced it has signed a...
View Article武田在即将召开的股东大会前宣布董事会候选人
日本大阪 (美国商业资讯)–武田(Takeda, TOKYO:4502/NYSE:TAK)今天宣布,公司董事会将在2022年6月29日召开的第146次股东普通大会上提名两位新的独立外部董事候选人。如果获批,新候选人Kimberly A. Reed和John Maraganore将于6月29日加入董事会,接替已宣布将要退休的Toshiyuki Shiga和Shiro...
View Article南非教学医院采用新型环境卫生干预后实现CRE超级细菌减少
约翰内斯堡 (美国商业资讯)–金山大学唐纳德·戈登医疗中心(Wits Donald Gordon Medical Centre, WDGMC)宣布的新研究结果首次显示,紫外线(UV)房间净化技术与手工清洁规程相结合,可将院内碳青霉烯类耐药肠杆菌目细菌(Carbapenem-resistant Enterobacterales,...
View ArticleFirst Patient in Japan Treated with Impella 5.5 with SmartAssist
DANVERS, Mass. The versatility and innovation of Abiomed’s (NASDAQ: ABMD) Impella 5.5 with SmartAssist, a minimally-invasive forward flow heart pump, is leading to continued adoption of the...
View ArticlePropanc Biopharma’s CEO Expresses Concern Over Disruption to Cancer Care...
MELBOURNE, Australia Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...
View Article武田薬品とニューヨーク科学アカデミーが2022年Innovators in Science Awardの受賞者を発表
大阪 & 米マサチューセッツ州ケンブリッジ (ビジネスワイヤ) — 武田薬品(TSE:4502/NYSE:TAK)とニューヨーク科学アカデミーは本日、第4回Innovators in Science...
View ArticleUniversity of Nottingham Ningbo China Students Win International Award With...
NINGBO, China With an ageing population and a changing social economic context, the traditional Chinese family support system for older adults has become more challenging. University of Nottingham...
View ArticleLevitasBio发布LeviCell EOS系统:开启样本处理和定性新时代
加利福尼亚州门洛帕克 (美国商业资讯)–LevitasBio, Inc.今天发布了LeviCell™ EOS系统,这是该公司的新一代细胞分离和富集解决方案,具有更高的通量和活性细胞同步靶向选择。利用经过现场验证的悬浮技术,研究人员现在能有效地将实验规模扩增16倍,每次运行处理多达4000万个细胞。LeviCell...
View Article武田和纽约科学院宣布2022年科学创新者奖得主
日本大阪和马萨诸塞州剑桥 (美国商业资讯)–武田(Takeda, TSE:4502/NYSE:TAK)和纽约科学院今天公布了第四届科学创新者奖(Innovators in Science Award)的获奖名单,获奖者们凭借在创新科学方面的卓越表现和不懈承诺,推动了胃肠病学研究领域的显著进步。每位获奖者均获得20万美元的非限制性奖金。 本新闻稿包含多媒体。此处查看新闻稿全文:...
View ArticleLevitasBioがLeviCell EOSシステムを発表:試料処理と特性評価の新時代を切り開く
米カリフォルニア州メンローパーク (ビジネスワイヤ) — LevitasBio, Inc.は本日、より高いスループットと標的生細胞の同時選択を特徴とする当社の次世代細胞分離・濃縮ソリューションLeviCell™...
View ArticlePhableCare Raises INR 187 Cr (USD 25 M) in Series B Funding
BANGALORE, India Bengaluru headquartered PhableCare, India’s largest chronic disease management company, has raised Series B funding of INR 187 crores (USD 25 Million) within one year of raising...
View Article首届Aster守护者全球护理奖公布入围的10名护士名单
阿联酋迪拜 (美国商业资讯)–Aster守护者全球护理奖(Aster Guardians Global Nursing...
View Article